Compound ID | 1883
Class: Beta-lactam (cephalosporin, first generation)
Spectrum of activity: | Gram-positive & Gram-negative |
Details of activity: | Binds to bacterial penicillin-binding proteins (PBP) and interferes with bacterial cell wall integrity and synthesis. Active against Gram-positive bacteria and moderately against Enterobacteriaceae but high resistance rates in Enterobacteriaceae |
Description: | Semisynthetic Cephalosporin, derived from Cephalosporin C. Oral application |
Year first mentioned: | 1972 |
Highest developmental phase: | Approved by FDA in 1974 |
Development status: | Discontinued |
Chemical structure(s): | |
Canonical SMILES: | CC1=C(C(=O)O)N2C(=O)[C@H]([C@H]2SC1)NC(=O)[C@@H](C3=CCC=CC3)N |
Isomeric SMILES: | CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)[C@@H](C3=CCC=CC3)N)SC1)C(=O)O |
InChI: | InChI=1S/C16H19N3O4S/c1-8-7-24-15-11(14(21)19(15)12(8)16(22)23)18-13(20)10(17)9-5-3-2-4-6-9/h2-3,6,10-11,15H,4-5,7,17H2,1H3,(H,18,20)(H,22,23)/t10-,11-,15-/m1/s1 |
InChI Key: | RDLPVSKMFDYCOR-UEKVPHQBSA-N |
Structure link: | https://pubchem.ncbi.nlm.nih.gov/compound/38103 |
External links: | |
Guide to Pharmacology: | cephradine |
Main Source: | https://pubmed.ncbi.nlm.nih.gov/4622888/ |
Citation: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8730689/ |